# Transcat Inc: overview

TRNS · Nasdaq · CIK 99302 · [Technology](/sectors/technology.md) · fiscal year ends Mar 27

Pages: [Overview](/companies/trns.md) · [Financials](/companies/trns/financials.md) · [Filings](/companies/trns/filings.md) · [Insiders](/companies/trns/insiders.md)

Latest reported revenue: [$92.9m](/filings/0001628280-26-052738.md) for Q1 FY2026, three months to 2026-06-27, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:Revenues, accession 0001628280-26-052738).

## Last eight quarters

| Line item | Unit | Q2 FY2024 (2024-09-28) | Q3 FY2024 (2024-12-28) | Q4 FY2024 (2025-03-29) | Q1 FY2025 (2025-06-28) | Q2 FY2025 (2025-09-27) | Q3 FY2025 (2025-12-27) | Q4 FY2025 (2026-03-28) | Q1 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [67.8](/filings/0001437749-25-033338.md) | [66.8](/filings/0001437749-26-002800.md) | [77.1 d](/filings/0001437749-26-018588.md) | [76.4](/filings/0001628280-26-052738.md) | [82.3](/filings/0001437749-25-033338.md) | [83.9](/filings/0001437749-26-002800.md) | [89.3 d](/filings/0001437749-26-018588.md) | [92.9](/filings/0001628280-26-052738.md) |
| Gross margin | % | [31.3%](/filings/0001437749-25-033338.md) | [29.5%](/filings/0001437749-26-002800.md) | [33.6% d](/filings/0001437749-26-018588.md) | [33.8%](/filings/0001628280-26-052738.md) | [32.5%](/filings/0001437749-25-033338.md) | [30.1%](/filings/0001437749-26-002800.md) | [34.1% d](/filings/0001437749-26-018588.md) | [33.1%](/filings/0001628280-26-052738.md) |
| Operating margin | % | [5.5%](/filings/0001437749-25-033338.md) | [3.1%](/filings/0001437749-26-002800.md) | [9.0% d](/filings/0001437749-26-018588.md) | [7.0%](/filings/0001628280-26-052738.md) | [4.3%](/filings/0001437749-25-033338.md) | [0.1%](/filings/0001437749-26-002800.md) | [4.8% d](/filings/0001437749-26-018588.md) | [4.0%](/filings/0001628280-26-052738.md) |
| Net margin | % | [4.8%](/filings/0001437749-26-002800.md) | [3.5%](/filings/0001437749-26-002800.md) | [5.8% d](/filings/0001437749-26-018588.md) | [4.3%](/filings/0001628280-26-052738.md) | [1.5%](/filings/0001437749-26-002800.md) | [(1.3%)](/filings/0001437749-26-002800.md) | [2.2% d](/filings/0001437749-26-018588.md) | [1.4%](/filings/0001628280-26-052738.md) |
| Diluted EPS | $ per share | [0.35](/filings/0001437749-25-033338.md) | [0.25](/filings/0001437749-26-002800.md) | not reported | [0.35](/filings/0001628280-26-052738.md) | [0.14](/filings/0001437749-25-033338.md) | [(0.12)](/filings/0001437749-26-002800.md) | not reported | [0.14](/filings/0001628280-26-052738.md) |
| Free cash flow | $m | [2.9 d](/filings/0001437749-25-033338.md) | [9.7 d](/filings/0001437749-26-002800.md) | [7.9 d](/filings/0001437749-26-018588.md) | [(1.0)](/filings/0001628280-26-052738.md) | [8.4 d](/filings/0001437749-25-033338.md) | [9.5 d](/filings/0001437749-26-002800.md) | [2.6 d](/filings/0001437749-26-018588.md) | [4.8](/filings/0001628280-26-052738.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2022-03-26) | FY2022 (2023-03-25) | FY2023 (2024-03-30) | FY2024 (2025-03-29) | FY2025 (2026-03-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [205](/filings/0001437749-24-018456.md) | [231](/filings/0001437749-25-018483.md) | [259](/filings/0001437749-26-018588.md) | [278](/filings/0001437749-26-018588.md) | [332](/filings/0001437749-26-018588.md) |
| Gross margin | % | [28.5%](/filings/0001437749-24-018456.md) | [29.6%](/filings/0001437749-25-018483.md) | [32.3%](/filings/0001437749-26-018588.md) | [32.1%](/filings/0001437749-26-018588.md) | [32.6%](/filings/0001437749-26-018588.md) |
| Operating margin | % | [6.9%](/filings/0001437749-24-018456.md) | [7.0%](/filings/0001437749-25-018483.md) | [7.6%](/filings/0001437749-26-018588.md) | [6.4%](/filings/0001437749-26-018588.md) | [4.0%](/filings/0001437749-26-018588.md) |
| Net margin | % | [5.6%](/filings/0001437749-24-018456.md) | [4.6%](/filings/0001437749-25-018483.md) | [5.3%](/filings/0001437749-26-018588.md) | [5.2%](/filings/0001437749-26-018588.md) | [1.6%](/filings/0001437749-26-018588.md) |
| Diluted EPS | $ per share | [1.50](/filings/0001437749-24-018456.md) | [1.40](/filings/0001437749-25-018483.md) | [1.63](/filings/0001437749-26-018588.md) | [1.57](/filings/0001437749-26-018588.md) | [0.57](/filings/0001437749-26-018588.md) |
| Free cash flow | $m | [7.5](/filings/0001437749-24-018456.md) | [7.5](/filings/0001437749-25-018483.md) | [19.3](/filings/0001437749-26-018588.md) | [25.8](/filings/0001437749-26-018588.md) | [19.6](/filings/0001437749-26-018588.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/trns/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [NEUBERGER BERMAN GROUP LLC](/funds/1465109.md) | 2026-06-30 | $72.1m | 777,366 |  | Reduced −48,372 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $67.4m | 727,010 |  | Added +52,095 |
| [Hood River Capital Management LLC](/funds/1578177.md) | 2026-06-30 | $55.8m | 601,541 |  | Reduced −13,013 |
| [Ophir Asset Management Pty Ltd](/funds/1844640.md) | 2026-06-30 | $42.9m | 462,016 |  | Reduced −83,499 |
| [Conestoga Capital Advisors, LLC](/funds/1163744.md) | 2026-06-30 | $41.7m | 449,557 |  | Reduced −62,961 |
| [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $40.0m | 431,671 |  | Reduced −182,582 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $38.4m | 414,057 |  | Added +6,896 |
| [BARROW HANLEY MEWHINNEY & STRAUSS LLC](/funds/313028.md) | 2026-06-30 | $37.1m | 399,983 |  | Added +72,541 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $29.4m | 317,015 |  | Added +19,287 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $25.5m | 275,296 |  | Added +13,263 |

## Recent filings

[All 933 filings](/companies/trns/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-10 | 16:15 ET | [8-K](/filings/0001628280-26-061346.md) | 5.07 Shareholder vote results | 0001628280-26-061346 |
| 2026-08-04 | 17:20 ET | [10-Q](/filings/0001628280-26-052738.md) | Quarterly report, period 2026-06-27 | 0001628280-26-052738 |
| 2026-08-04 | 16:07 ET | [8-K](/filings/0001628280-26-052553.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-052553 |
| 2026-07-23 | 08:00 ET | [DEF 14A](/filings/0001140361-26-029371.md) | Proxy statement, period 2026-09-09 | 0001140361-26-029371 |
| 2026-05-27 | 16:36 ET | [10-K](/filings/0001437749-26-018588.md) | Annual report, period 2026-03-28 | 0001437749-26-018588 |
| 2026-05-26 | 16:07 ET | [8-K](/filings/0001437749-26-018375.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-018375 |
| 2026-05-19 | 16:30 ET | [8-K](/filings/0001206774-26-000287.md) | 5.02 Departure or appointment of officers or directors | 0001206774-26-000287 |
| 2026-03-09 | 16:10 ET | [8-K](/filings/0001206774-26-000129.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001206774-26-000129 |
| 2026-02-03 | 16:06 ET | [8-K](/filings/0001437749-26-002801.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-002801 |
| 2026-02-03 | 16:06 ET | [10-Q](/filings/0001437749-26-002800.md) | Quarterly report, period 2025-12-27 | 0001437749-26-002800 |

## Latest annual report

[Form 10-K for the fiscal year ended Mar 28, 2026](/filings/0001437749-26-018588.md), filed May 27, 2026.

## Forecast league

Q2 FY2026, the quarter ended 2026-09-27, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/f9a8cd16-95f2-4915-bf56-3ac9f0dfbf6d)

## About the filer

- CIK: 99302
- Tickers: TRNS
- Exchange: Nasdaq
- SIC code: 3825 Instruments For Meas & Testing of  Electricity & Elec Signals
- State of incorporation: OH
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 12:40 ET. No prices; not investment advice.